eGenesis Announces IND Clearance for EGEN-2784 in Kidney Transplant
The IND clearance supports a Phase 1/2/3 study to determine the safety and efficacy of their porcine-derived kidney in patients with dialysis-dependent ESKD, over the age of 50, who are currently on a transplant waitlist.
Read the full article » | Posted 09-15-2025
Related Articles
- Drs. Monica Farcus and Jeffrey Perl Win the Mitchell Award for Health System Innovation Posted 01-16-2026
- Nephrodite Wins FDA Breakthrough Device Designation for “Holly” Posted 01-16-2026
- Meet the Dutch Neokidney: a New Suitcase Hemodialysis Machine Posted 01-16-2026
- Watch an AKF Webinar on Advancements in Home Dialysis Posted 12-17-2025

